Human DBC1 (Deleted in Breast Cancer 1; KIAA1967; CCAR2) is a protein implicated in the regulation of apoptosis, transcription and histone modifications. Upon DNA damage, DBC1 is phosphorylated by ATM/ATR on Thr454 and this modification increases its inhibitory interaction with SIRT1, leading to p53 acetylation and p53-dependent apoptosis. Here, we report that the inhibition of SIRT1 by DBC1 in the DNA damage response (DDR) also depends on Chk2, the transducer kinase that is activated by ATM upon DNA lesions and contributes to the spreading of DNA damage signal. Indeed we found that inactivation of Chk2 reduces DBC1-SIRT1 binding, thus preventing p53 acetylation and DBC1-induced apoptosis. These events are mediated by Chk2 phosphorylation o...
AbstractThe human BAP1 deubiquitinating enzyme is a chromatin-bound transcriptional regulator and tu...
The DNA damage response (DDR) protects cells against genomic instability. Surprisingly, little is kn...
mTOR signalling is commonly dysregulated in cancer. Concordantly, mTOR inhibitors have demonstrated ...
Human DBC1 (Deleted in Breast Cancer 1; KIAA1967; CCAR2) is a protein implicated in the regulation o...
Human DBC1 (Deleted in Breast Cancer 1; KIAA1967; CCAR2) is a nuclear protein with controversial eff...
Human DBC1 (deleted in breast cancer-1; KIAA1967) is a nuclear protein that, in response to DNA dama...
Human DBC1 (Deleted in Breast Cancer-1; KIAA1967) is a nuclear protein involved in apoptosis, transc...
SummaryDBC1 (deleted in breast cancer 1), also known as CCAR2 or KIAA1967, is an important negative ...
The NAD-dependent deacetylase SirT1 regulates gene silencing and genomic stability in response to nu...
BACKGROUND: DBC1/KIAA1967 (deleted in breast cancer 1) is a putative tumour-suppressor gene cloned f...
This is an open-access article distributed under the terms of the Creative Commons Attribution Licen...
The protein Deleted in Breast Cancer-1 is a regulator of several transcription factors and epigeneti...
AbstractThe checkpoint kinase Chk2 is an effector component of the ATM-dependent DNA damage response...
Following genotoxic stress, cells activate a complex kinase-based signaling network to arrest the ce...
DBC1 (deleted in breast cancer 1), also known as CCAR2 or KIAA1967, is an important negative regulat...
AbstractThe human BAP1 deubiquitinating enzyme is a chromatin-bound transcriptional regulator and tu...
The DNA damage response (DDR) protects cells against genomic instability. Surprisingly, little is kn...
mTOR signalling is commonly dysregulated in cancer. Concordantly, mTOR inhibitors have demonstrated ...
Human DBC1 (Deleted in Breast Cancer 1; KIAA1967; CCAR2) is a protein implicated in the regulation o...
Human DBC1 (Deleted in Breast Cancer 1; KIAA1967; CCAR2) is a nuclear protein with controversial eff...
Human DBC1 (deleted in breast cancer-1; KIAA1967) is a nuclear protein that, in response to DNA dama...
Human DBC1 (Deleted in Breast Cancer-1; KIAA1967) is a nuclear protein involved in apoptosis, transc...
SummaryDBC1 (deleted in breast cancer 1), also known as CCAR2 or KIAA1967, is an important negative ...
The NAD-dependent deacetylase SirT1 regulates gene silencing and genomic stability in response to nu...
BACKGROUND: DBC1/KIAA1967 (deleted in breast cancer 1) is a putative tumour-suppressor gene cloned f...
This is an open-access article distributed under the terms of the Creative Commons Attribution Licen...
The protein Deleted in Breast Cancer-1 is a regulator of several transcription factors and epigeneti...
AbstractThe checkpoint kinase Chk2 is an effector component of the ATM-dependent DNA damage response...
Following genotoxic stress, cells activate a complex kinase-based signaling network to arrest the ce...
DBC1 (deleted in breast cancer 1), also known as CCAR2 or KIAA1967, is an important negative regulat...
AbstractThe human BAP1 deubiquitinating enzyme is a chromatin-bound transcriptional regulator and tu...
The DNA damage response (DDR) protects cells against genomic instability. Surprisingly, little is kn...
mTOR signalling is commonly dysregulated in cancer. Concordantly, mTOR inhibitors have demonstrated ...